Article

Astigmatism is common

Nearly one-half of patients who require vision correction are significantly astigmatic in at least one eye, according to a study sponsored by Johnson & Johnson Vision Care and published in Eye & Contact Lens.

Jacksonville, FL-Nearly one-half of patients who require vision correction are significantly astigmatic in at least one eye, according to a study sponsored by Johnson & Johnson Vision Care and published in Eye & Contact Lens.

To conduct this study, researchers obtained a database of spectacle prescriptions from a United Kingdom optical retail chain, and calculated the prevalence of astigmatism for various thresholds by eye and by patient. The analysis included patients aged 8 to 70 years. Astigmatism of 0.75 D was used as the threshold for analysis.

Of the 11,624 patients in the database, nearly one-half (47.4%) demonstrated significant astigmatism (greater than or equal to 0.75 D) in at least one eye, and nearly one-quarter (24.1%) exhibited significant astigmatism in both eyes. This proportion was higher for patients with myopia, of whom 54.9% demonstrated astigmatism in at least one eye, and 31.7% in both eyes. The prevalence of astigmatism was about twice as high in myopia as in hyperopia and increased with spherical refractive error.

Of the 47.4% of patients who had astigmatism, nearly one-half had significant astigmatism in one eye only.

"These findings provide useful information on the proportion of potential soft contact lens wearers requiring an astigmatic correction," said co-author Graeme Young, PhD, FCOptom, DCLP.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.